General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-07 | 2024-03 | -0.09 | -0.17 | -0.08 | -88.89% |
2024-03-05 | 2023-12 | -0.08 | -0.12 | -0.04 | -50.00% |
2024-03-05 | 2023-12 | -0.08 | N/A | N/A | N/A |
2023-11-06 | 2023-09 | -0.11 | -0.03 | 0.08 | 72.73% |
2023-11-06 | 2023-09 | -0.11 | N/A | N/A | N/A |
2023-08-07 | 2023-06 | -0.11 | -0.1 | 0.01 | 9.09% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-09 | Wedbush | Upgrade | Outperform | Outperform |
2023-10-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-09-21 | Wedbush | Upgrade | Outperform | Outperform |
2023-09-21 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-09-20 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
2023-07-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-06 | BARBER DANIEL | Chief Executive Officer | 883.30K | Stock Award(Grant) |
2024-03-06 | BOYD PETER E | Officer | 246.00K | Stock Award(Grant) |
2024-03-06 | BRAENDER LORI J | General Counsel | 323.76K | Stock Award(Grant) |
2024-03-06 | JUNG CASSIE | Officer | 249.23K | Stock Award(Grant) |
2021-08-25 | KENDALL KEITH J. | Chief Executive Officer | 637.15K | Stock Gift |
2024-03-06 | KRAUS CARL N | Officer | 262.50K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Bratton Capital Management, LP | 9.81M | 16.19M | 14.70% |
2023-06-29 | Vanguard Group Inc | 1.56M | 2.57M | 2.34% |
2023-06-29 | Renaissance Technologies, LLC | 1.23M | 2.03M | 1.84% |
2023-06-29 | Armistice Capital, LLC | 1.16M | 1.91M | 1.74% |
2023-09-29 | Vahanian & Associates Financial Planning Inc. | 722.11K | 1.10M | 1.08% |
2023-06-29 | Bracebridge Capital, LLC | 428.57K | 707.14K | 0.64% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 932.70K | 1.54M | 1.40% |
2023-06-29 | Vanguard Extended Market Index Fund | 493.68K | 814.56K | 0.74% |
2023-05-30 | Fidelity Extended Market Index Fund | 197.28K | 455.72K | 0.30% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 142.36K | 234.89K | 0.21% |
2023-08-30 | iShares Micro Cap ETF | 92.79K | 152.17K | 0.14% |
2023-05-30 | Fidelity Total Market Index Fund | 78.34K | 180.97K | 0.12% |
$AQST Again 10/06/21 CEO states ample cash and Credit Facilities to carry them through FDA approval and LAUNCH of Libervant no offering.
$AQST Step by step inch by inch……..then slowly I
$AQST The pipeline is loaded with GOLD.
$AQST Clarification on dosage to weight which has been addressed the drop was manipulation by MM and shorts given the delay I saw it as an opportunity to load more and boy did I. Targets are 7.50L-16.00M-27.00H. Good luck!
$AQST Libervant will be a game changer for the patient and the care giver. The current med is a gel applied to the anus while the individual is going through a seizure think about that.
$AQST 10/06/21 CEO states AQST has adequate cash and Credit Facility access to carry them through FDA approval and LAUNCH of Libervant….NO DILUTION in near future pull the trigger!
$AQST 10/06/21 CEO states we have sufficient cash and Credit Facility to carry us through FDA approval and LAUNCH of Libervant in USA . No dilution in sight!
$AQST Analyst ratings are all a buy from 7.00 low 16.88 mid to 28.00 high it’s a home run any way u look at it.
$AQST Is going to go people you might as well jump in and ride with it. It’s only money- - -BIG MONEY.
$AQST Is going to go people you might as well jump in and ride with it. It’s only money- - -BIG MONEY.
$AQST Buy now or chase later!
$AQST At least a few have still got some gonads
$AQST $ 13,000.20 OUCH!
$AQST Get it while cheap 4.11=15.00 in 3 months
$AQST Keep your eye on the prize and buy 4.19=15.00
Looking for an entry point. I just can’t see jumping in until after the $5.75 has been broken. The Suboxone part is luring, always will have junkies and it’s the #1 prescribed medicine for opiate recovery. Not a whole lot of other choices on market. I’ll bet that drug carries the company. Idk, just speculating from website and 2min DD
Hope to be on the team, will be watching. GLTA
$AQST Keep the faith when this stock starts to move it will be fast check out the 2yr chart and some did on the drug
$AQST You snoooz you loooz…..big time!
$AQST Those peckerwoods don’t give up the tide gonna change
$AQST Let my people go—Let my people go you sinners !